Sigyn Therapeutics, Inc.
SIGY
$2.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 85.60K | 500.00 | 12.90K | 12.10K | 164.80K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | 50.00K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.30K | 55.20K | 9.10K | 54.30K |
| Total Current Assets | 85.60K | 1.80K | 68.10K | 21.20K | 269.10K |
|
|
|||||
| Total Current Assets | 85.60K | 1.80K | 68.10K | 21.20K | 269.10K |
| Net Property, Plant & Equipment | -- | -- | 105.50K | 121.80K | 137.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 50.00K | 50.00K | 70.70K | 70.70K | 20.70K |
| Total Assets | 135.60K | 51.80K | 244.30K | 213.70K | 427.40K |
|
|
|||||
| Total Accounts Payable | 773.60K | 729.80K | 672.00K | 608.40K | 611.60K |
| Total Accrued Expenses | 2.28M | 2.19M | 2.01M | 1.87M | 1.76M |
| Short-term Debt | 750.90K | 2.57M | 2.40M | 2.07M | 1.83M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 72.30K | 69.90K | 67.70K |
| Total Finance Division Other Current Liabilities | 185.30K | 3.40K | 300.00 | 1.70K | 0.00 |
| Total Other Current Liabilities | 185.30K | 3.40K | 300.00 | 1.70K | 0.00 |
| Total Current Liabilities | 3.99M | 5.49M | 5.15M | 4.62M | 4.28M |
|
|
|||||
| Total Current Liabilities | 3.99M | 5.49M | 5.15M | 4.62M | 4.28M |
| Long-Term Debt | 2.06M | -- | -- | -- | -- |
| Short-term Debt | 750.90K | 2.57M | 2.40M | 2.07M | 1.83M |
| Capital Leases | -- | -- | 37.50K | 56.40K | 74.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.05M | 5.49M | 5.19M | 4.67M | 4.35M |
|
|
|||||
| Common Stock & APIC | 11.46M | 11.36M | 10.41M | 10.22M | 10.24M |
| Retained Earnings | -17.38M | -16.80M | -15.35M | -14.68M | -14.16M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -5.92M | -5.44M | -4.95M | -4.46M | -3.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.92M | -5.44M | -4.95M | -4.46M | -3.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.92M | -5.44M | -4.95M | -4.46M | -3.92M |
|
|
|||||